Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    InMed Pharmaceuticals Inc...

    NASDAQ: INM · Real-Time Price · USD
    2.32
    -0.02 (-0.85%)
    At close: Aug 15, 2025, 9:59 AM
    -0.85%
    Bid 2.25
    Market Cap 4.65M
    Revenue (ttm) 6.87M
    Net Income (ttm) -11.65M
    EPS (ttm) -11.65
    PE Ratio (ttm) -0.2
    Forward PE n/a
    Analyst n/a
    Ask 2.36
    Volume 15,422
    Avg. Volume (20D) 3,147,882
    Open 2.30
    Previous Close 2.34
    Day's Range 2.28 - 2.38
    52-Week Range 1.72 - 15.70
    Beta 0.47

    About INM

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol INM
    Website n/a
    Full Company Profile
    1 month ago
    +57.96%
    InMed shares are trading higher after the company ... Unlock content with Pro Subscription
    6 months ago
    +2.02%
    InMed Pharmaceuticals shares are trading higher after the company announced that INM-901 reduced Alzheimer 's-related inflammation in a preclinical study.
    news image

    2 weeks ago · newsfilecorp.com

    InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025

    Long-term INM-901 treatment in preclinical studies in advanced disease continues to show multi-modal activity Vancouver, British Columbia--(Newsfile Corp. - July 28, 2025) - InMed Pharmaceuticals Inc....

    news image

    1 month ago · newsfilecorp.com

    InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

    Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of propri...

    news image

    1 month ago · newsfilecorp.com

    InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

    Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of propri...

    news image

    1 month ago · newsfilecorp.com

    InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study

    Demonstrates statistically significant reduction of pro-inflammatory cytokines, including IL-6, IL-1β, IL-2, and KC/Gro Significantly reduces levels of inflammasome marker, NLRP3, a key contributor to...

    news image

    2 months ago · newsfilecorp.com

    InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA

    Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of propri...

    Add to Watchlist